Active salt - Alendronate sodium
Fosamax is used in men and women to treat or prevent osteoporosis that is caused by menopause or by taking steroids. Fosamax is also used to increase bone mass in men who have osteoporosis, and to treat Paget's disease of bone in men and women.Bisphosphonates are synthetic analogs of pyrophosphate that bind to the hydroxyapatite found in bone. Alendronate sodium is chemically described as (4-amino-1-hydroxybutylidene) bisphosphonic acid monosodium salt trihydrate. Alendronate sodium is a white, crystalline, nonhygroscopic powder. It is soluble in water, very slightly soluble in alcohol, and practically insoluble in chloroform. Fosamax is used to treat osteoporosis and Paget's disease of bone. It is taken by mouth. Use is often recommended together with vitamin D, calcium supplementation, and lifestyle changes.
Strong bones play a very important role throughout the human body because they give a specific shape to the body. Strong bones are the key for men and women. Usually after menopause, women's bones get thin and weak. This condition of low bone density in women is known as osteopenia. Yes, for those women who have reached the phase of menopause, the strength of bones should improve with supplement pills. And one such is "Fosamax (Alendronate Sodium)." This condition that every woman reaches at one point in life can be easily treated with the help of oral medications. It is a bisphosphonate that helps effectively in weakening the bones in the body. Fosamax pills are used by men and women for osteoporosis, which is caused by varied reasons in both the sexes. To treat men with this osteoporosis caused by steroids. Women use Fosamax treats the condition of osteopenia.
Women use Fosamax treats the condition of osteopenia. The bisphosphonates in Fosamax helps in binding and strengthening the bones, which in women's body and prevents the risk of bone fractures, ribs, elbows etc. After the right doctor consultation on the pills can start according to the procedure of use prescribed. Back in 1880, Sir Astley Paston Cooper, an American physician, using the term "osteoporosis" that explains the decrease in bone density in the body. In general, women are all prescribed the same ones who have crossed the age of 50 yearsare detected with osteopenia. The prescription is only after by controlling the bone density in the body, which is determined by means of various tests. In 1995, Fosamax was introduced and prescribed for low bone density.
Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.
Treatment Of Osteoporosis In Postmenopausal Women:
The optimal duration of use has not been determined. The safety and effectiveness of FOSAMAX for the treatment of osteoporosis are based on clinical data of four years duration. All patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. Patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. Patients who discontinue therapy should have their risk for fracture re-evaluated periodically.